文献速递银屑病与炎症性皮肤病

抗菌肽LL37诱导人角质形成细胞中Toll样受体8并放大IL-36γ与IL-17C

Cathelicidin Antimicrobial Peptide LL37 Induces Toll-Like Receptor 8 and Amplifies IL-36γ and IL-17C in Human Keratinocytes.
PubMed 文献 · J Invest Dermatol · 2022-12-07

本研究利用培养的角质形成细胞和银屑病患者皮肤样本,探讨LL37与TLR7/8在角质形成细胞中的关系及其在银屑病发病通路中的作用。结果显示LL37可诱导角质形成细胞中TLR7/8表达,TLR8而非TLR7功能性诱导多种银屑病相关分子,IL-36受体拮抗抗体可抑制LL37诱导的IL-17C。银屑病表皮中LL37、TLRs、IL-17C和IL-36γ表达增加且共表达,结论为LL37通过诱导IL-36γ激活角质形成细胞TLR8并诱导IL-17C。

要点

  • LL37可诱导角质形成细胞中TLR7/8表达。
  • TLR8而非TLR7功能性诱导多种银屑病相关分子。
  • IL-36受体拮抗抗体可抑制LL37诱导的IL-17C。

核心结论

  • LL37在角质形成细胞中激活TLR8,并通过诱导IL-36γ进而诱导IL-17C。
  • 调控角质形成细胞中的TLR8或LL37可能是银屑病炎症的潜在治疗策略。

研究设计与样本

  • 研究使用培养的角质形成细胞和银屑病患者皮肤样本。

主要发现

  • LL37在角质形成细胞中诱导TLR7/8。
  • TLR8而非TLR7功能性诱导多种银屑病相关分子,而阻断TLR7/8未改变IL-17C。
  • LL37与自身RNA/DNA共刺激未显示交互作用,但LL37本身可促进银屑病相关基因。
  • IL-36受体拮抗抗体抑制了LL37诱导的IL-17C。
  • 银屑病表皮中LL37、TLRs、IL-17C和IL-36γ表达增加且彼此共表达。

临床怎么用

  • 作者认为调控角质形成细胞中的TLR8或LL37可能是银屑病炎症的潜在治疗策略。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

LL37 is produced by skin injury and bacterial infection and plays an important role in the early stages of psoriasis. In particular, the intracellular receptors toll-like receptors (TLR)3, TLR7, TLR8, and TLR9 are thought to be involved in the pathogenesis of psoriasis in conjunction with LL37, but the interaction between TLR7/8 and LL37 in keratinocytes (KCs) remains unclear. This study aimed to clarify the relationship between LL37 and TLR7/8 in KCs and their involvement in the pathogenetic pathways seen in psoriasis using cultured KCs and skin samples of patients with psoriasis. TLR7/8 was induced by LL37 in KCs. TLR8 but not TLR7 functionally induced many psoriasis-related molecules, whereas IL-17C was not altered by the blockade of TLR7/8. Although costimulation of LL37 with self-RNA/DNA did not show any interaction, LL37 itself would promote psoriasis-related genes. IL-36 receptor antagonistic antibody suppressed IL-17C induced by LL37. In psoriatic epidermis, LL37, TLRs, IL-17C, and IL-36γ expressions were increased and coexpressed with each other. Thus, we concluded that LL37 activates TLR8 in KCs and induces IL-17C through the induction of IL-36γ. Regulation of TLR8 or LL37 in KCs could be a potential therapeutic strategy for psoriatic inflammation.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Miura S, Garcet S, Li X, et al. Cathelicidin Antimicrobial Peptide LL37 Induces Toll-Like Receptor 8 and Amplifies IL-36γ and IL-17C in Human Keratinocytes. J Invest Dermatol. 2022. PMID: 36496195. doi:10.1016/j.jid.2022.10.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。